CHOLERA VACCINE Price
Active Substance: Vibrio cholerae El Tor Inaba (ATTC 14033), Vibrio cholerae El Tor Ogawa 17, Vibrio cholerae Inaba (NIH 35 A 3), Vibrio cholerae Ogawa (NIH 41).
Overview
Welcome to Dwaey, specifically on CHOLERA VACCINE page.
This medicine contains an important and useful components, as it consists of
Vibrio cholerae El Tor Inaba (ATTC 14033), Vibrio cholerae El Tor Ogawa 17, Vibrio cholerae Inaba (NIH 35 A 3), Vibrio cholerae Ogawa (NIH 41)is available in the market in concentration
Name
Oral Cholera Vaccine (Vibrio cholerae 01 Inaba & Ogawa strains)
Precaution
Immunisation should be delayed in patients suffering from acute febrile illness or acute GI illness. Not recommended for use in children <2 yr. Limited data on efficacy and safety of the vaccine usage in HIV-infected patients. Additional protective measures should be undertaken as the vaccine does not provide complete protection against cholera infection.
Indication
Cholera, Protection against cholera in adult & children >2 yr.
Contra indication
Hypersensitivity. Acute stomach disorder or infection w/ fever (postpone vaccination).
Side Effect
GI disturbances, headache, dizziness and respiratory symptoms. Fever and malaise, hypersensitivity reactions and neurological symptoms.
Pregnancy Category ID
0
Mode of Action
Cholera vaccine is available as oral preparations containing either live attenuated or inactivated strains. Oral cholera vaccines appear to be more effective than parenteral vaccines. It may be used in adults and children aged ?2 yr who are traveling to areas of risk.
Interaction
Not to be used within 3 wk of immunoglobulin admin. Reduced response may occur in patients who are concurrently receiving immunosuppressant treatment e.g. antineoplastics, corticosteroids at therapeutic doses. Oral, encapsulated typhoid vaccine should not be admin within 8 hr of cholera vaccine admin.
Pregnancy Category Note
Information not available
Adult Dose
Child Dose
Renal Dose
Administration
